Summary:
Clinical Trials of Texas, Inc. is looking for children 2-12 years of age with plaque psoriasis to participate in a research study. The study will be evaluating Vectical™ topical cream, which is currently FDA approved for adults 18 and older.
Qualified Participants Must:
• Be 2 to 12 years of age
•
Have plaque psoriasis on 5-35% of body (not including face and scalp
•
Have no other types of psoriasis
•
Have willingness to discontinue certain psoriasis treatments during study
•
Additional criteria may apply
Qualified Participants May Receive:
Study-related monitoring by a Board Certified Dermatologist, diagnostic testing, and study medication for up to 2 weeks at no cost.